What You Should Know:
- ARTIS Ventures, a pioneer in this "TechBio" revolution, announces the closing of its second fund, TechBio II, with $200M focused on healthcare and biology innovation.
- The fund aims to support early-stage companies to transform human health and well-being by leveraging growing data sets, advanced analytics, and insights.
TechBio II Investment Thesis
Diseases once deemed incurable now have hope, personalized therapies are becoming a reality, and the human body
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Cytovale Secures $84M for Transformative Sepsis Diagnostic Tool
What You Should Know:
Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced it has raised $84 million in Series C funding led by Norwest Venture Partners with participation by additional new investors Sands Capital and Global Health Investment Corporation (GHIC).The financing included participation from other new and existing investors, as well as the conversion of
Read More
Intuitive Ventures Closes $150M Fund to Fuel Revolution in Minimally Invasive Care
What You Should Know:
- Intuitive Ventures, an early-stage venture capital fund dedicated to reimagining minimally invasive care, announced the close of its second fund at $150M.
- The funding signifies their unwavering commitment to supporting visionary founders who are transforming healthcare through precision diagnostics, secure digital ecosystems, and improved access to coordinated care.
Building on a Strong Foundation
In 2020, Intuitive Ventures launched its inaugural fund of
Read More
Alcohol Tracking App Sunnyside Raises $11.5M to Support Healthier Drinking Habits
What You Should Know:
- Sunnyside, an app and program that helps people build healthier habits around drinking alcohol, today announced $11.5M in Series A funding and the hire of Steve Lloyd as Chief Product and Technology Officer.
- The funding round was led by Motley Fool Ventures with major participation from Will Ventures, bringing the company's total funding to $14.6M to date. Additional Series A investors include Uncork Capital, Offline Ventures, Joyance
Read More
Pepper Bio, the ’Google Maps for Drug Discovery’, Secures $6.5M to Streamline R&D
What You Should Know:
Pepper Bio, the “Google Maps for drug discovery,” today announced an oversubscribed $6.5 million seed round led by NFX with participation from Silverton Partners, Merck Digital Sciences Studio, Mana Ventures, Tensility Ventures, VSC Ventures, and more. Pepper Bio is the world’s first transomics company, which maps data across all the -omics layers and translates it into the fastest route for discovering new drugs, finding new uses for existing
Read More
Culmination Bio Raises $10M to Bring Longitudinal Health Data to Biopharma
What You Should Know:
Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures.As a spinoff from Intermountain Health, Culmination Bio maintains exclusive rights to a physical library and cloud-based data lake covering over 40 years of de-identified patient electronic health records and biospecimen data.
Data
Read More
Vivodyne Secures $38M for AI-Powered Drug Discovery Platform
What You Should Know:
- Vivodyne, a biotech company that accelerates drug discovery by testing therapies on lab-grown human organs raises $38M in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS Ventures, MBX Capital, and Bison Ventures.
- The funding will support Vivodyne's development of a clinically predictive AI stack and discovery pipeline, which utilizes lab-grown human organ tissues to identify novel therapeutic targets and predict patient
Read More
PayGround Secures $19.7M to Expand Healthcare Fintech Payments Platform
What You Should Know:
- PayGround, a Gilbert, AZ-based healthcare fintech payments platform, announced closing a $19.7M oversubscribed Series A financing led by SixThirty with participation from Rally Ventures, IA Capital Group, FCA Venture Partners and Plug and Play Ventures.
- The funding will bolster the company’s rapid expansion into hospitals and health systems, building on its success in the ambulatory market, as well as grow its senior leadership
Read More
RepeatMD Secures $50M to Automate Revenue Generation in the Aesthetics & Wellness Industry
What You Should Know:
RepeatMD, a SaaS company leveraging Inbound Revenue to increase sales for aesthetic and wellness practices, has secured $50 million in Series A funding, including a $10 million debt facility from Silicon Valley Bank.This funding marks a significant milestone in RepeatMD's mission to deliver superior revenue efficiency to growing practices and to enhance their patients’ experience.
Bolstering New and Growing Practices
RepeatMD has successfully secured a
Read More
Medmo Secures $9M to Streamline Medical Imaging
What You Should Know:
Medical imaging technology company Medmo announced a $9 million funding round led by Lerer Hippeau,alongside existing investors Jerusalem Venture Partners (JVP), C2 Ventures and Stone IsraVentures.In addition, an array of notable angel investors participated, including Elliot Cohen, founder of PillPack (acquired by Amazon), and Klara (acquired by ModMed) Co-founders Simon Bolz and Dr. Simon Lorenz. The additional
Read More
